ArticleJournal, genetic engineering & biotechnology2026
Discovering potential key biomarkers and molecular mechanisms in Chronic Obstructive Pulmonary Disease and rheumatoid arthritis using integrated bioinformatics and machine learning approaches.
Article in Journal, genetic engineering & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChronic Obstructive Pulmonary Disease (COPD) and Rheumatoid Arthritis (RA) are among the leading causes of illness and mortality globally. Many studies claim that these diseases are interconnected. However, the underlying molecular processes and shared biomarkers between RA and COPD are still undiscovered.
methodsThis research is aimed at discovering the key potential biomarkers and mechanisms in RA and COPD, incorporating several Bioinformatics and Machine Learning (ML) approaches via R programming. Several validation methods are also applied to validate the key potential biomarkers.
resultsBy performing the differential expression analysis, we have discovered 90 common Differentially Expressed Genes (DEGs) between RA and COPD. From the Gene Set Enrichment analysis, we get the top molecular mechanisms related to the common DEGs. From the Protein Protein Interaction analysis, we get the candidate hub genes among the common DEGs. Among all the ML approaches, ElasticNet outperforms with the highest accuracy of 91.52% with a set of important genes. By intersecting the candidate hub genes and the ElasticNet important genes, we get four candidate genes, ETS1, YY1, CREBP5, and GTF2H1. Receiver Operating Characteristic (ROC) curve and Expression analysis show robust discriminatory efficacy for all four genes, while nomogram modeling further validates their predictive correlations with RA and COPD. Finally, the candidate transcription factors, microRNAs and drugs related to the potential biomarkers are also suggested.
conclusionIn conclusion, this research identifies the key potential molecular mechanisms and four potential biomarkers between RA and COPD. These findings could potentially improve our understanding of the molecular mechanisms behind COPD and RA by providing a preliminary basis for future experimental and clinical studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.